E

Eton Pharmaceuticals
D

ETON

17.370
USD
0.41
(2.42%)
مغلق
حجم التداول
6,351
الربح لكل سهم
0
العائد الربحي
-
P/E
-116
حجم السوق
465,820,583
أصول ذات صلة
ABT
ABT
1.930
(1.47%)
132.820 USD
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
AZN
AZN
1.940
(2.75%)
72.440 USD
BMY
BMY
1.000
(2.02%)
50.560 USD
GSK
GSK
-0.120
(-0.31%)
39.070 USD
JNJ
JNJ
1.720
(1.11%)
156.120 USD
LLY
LLY
10.33
(1.27%)
823.96 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
NVS
NVS
3.000
(2.69%)
114.320 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
SNY
SNY
1.360
(2.51%)
55.470 USD
المزيد
الأخبار المقالات

العنوان: Eton Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.